Progressive Multifocal Leukoencephalopathy Brain Infection
Gilenya May Cause Brain Infection. Our firm is investigating potential lawsuits on behalf of Gilenya users who developed progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection. The U.S. Food and Drug Administration (FDA) reported cases of PML among Gilenya users in 2013, and again in August 2015. The … [Read more...] about Progressive Multifocal Leukoencephalopathy Brain Infection
Find a Skilled Attorney for Your Gilenya Lawsuit
Do you know someone who died unexpectedly while taking the multiple sclerosis drug Gilenya? Gilenya is currently being reviewed by regulators in the U.S. and Europe following the sudden deaths of several patients being treated with the drug. If someone you love died suddenly after starting treatment with Gilenya, you may be entitled … [Read more...] about Find a Skilled Attorney for Your Gilenya Lawsuit
Health Canada Strengthens Safety Warnings for Multiple Sclerosis Drug Gilenya
Health Canada, Canada’s health regulatory agency, has updated the label information for the multiple sclerosis drug Gilenya (fingolimod) to include stronger safety warnings on the risk of skin cancer and the rare brain infection progressive multifocal leukoencephalopathy (PML), which can be fatal. Gilenya, a prescription drug, is … [Read more...] about Health Canada Strengthens Safety Warnings for Multiple Sclerosis Drug Gilenya
Gilenya Heart Warning
MS Drug Gilenya Heart Warning. Gilenya Risk Of Serious Complications Prior Patients With Heart Trouble Health officials in the United Kingdom are following a trend set by domestic regulators in issuing a health warning on the multiple sclerosis (MS) drug Gilenya (fingolimod) because it poses the risk of serious … [Read more...] about Gilenya Heart Warning
Serious Brain Infection In Gilenya Patient
The Serious Side Effects of Gilenya We’ve been following serious side effects linked to patients taking multiple sclerosis (MS) medication Gilenya(gingolimod). Now, a serious brain infection has been reported in a Gilenya patient. of Gilenya was approved for the treatment of relapsing-remitting MS and is used to reduce the frequency … [Read more...] about Serious Brain Infection In Gilenya Patient
Calls for Significant Gilenya Restrictions
A Safety Group Calls For Gilenya Restriction. A patient safety group believes access to the multiple sclerosis drug Gilenya should be severely restricted because its short time on the market has been plagued by reports of fatal adverse reactions. According to a report at Pharmalot.com, the Institute for Safe Medicine … [Read more...] about Calls for Significant Gilenya Restrictions
Gilenya Safety Review Hits Sales
Gilenya Safety Review. Eleven deaths among people taking the multiple sclerosis drug Gilenya have caused it to lose market share since it hit the U.S. market in late-2010. According to a Bloomberg report, Gilenya’s share of the market for immunomodulatory drugs used in the treatment of MS from from 6.2 percent to 6.1 in … [Read more...] about Gilenya Safety Review Hits Sales
